COLD vs VRTX · rev $2.67B vs P/E 30, rev $12.00B
Americold Realty Trust (COLD) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
Americold Realty Trust (COLD) is a reit - industrial company listed on US.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported COLD revenue for 2024-12-31 was $2.67B. Net income was -$94.7M. Revenue was down 0.3% from 2023-12-31 to 2024-12-31. COLD currently screens at market cap $4.75B.
Latest reported VRTX revenue for 2025-12-31 was $12.00B. Net income was $3.95B. Revenue was up 8.9% from 2024-12-31 to 2025-12-31. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
COLD currently screens at market cap $4.75B. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the COLD and VRTX stock pages for the full models.
Not investment advice.